Mountain View, CA, United States of America

David Brian Karpf

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 5.1

ph-index = 5

Forward Citations = 84(Granted Patents)


Location History:

  • Monte Sereno, CA (US) (2012 - 2018)
  • Mountain View, CA (US) (2016 - 2024)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Inventor David Brian Karpf

Introduction

David Brian Karpf is a notable inventor based in Mountain View, California, recognized for his significant contributions to the pharmaceutical industry. With a remarkable portfolio of 14 patents, Karpf has paved the way for advancements in the development of innovative therapies.

Latest Patents

Among his most recent innovations are his patents related to PTH (Parathyroid Hormone) compounds. These patents describe pharmaceutical compositions comprising a PTH compound that exhibits a pharmacokinetic profile with a peak-to-trough ratio of less than 4 following subcutaneous administration within one injection interval. This breakthrough in PTH compounds holds potential for improved therapeutic outcomes in patient care.

Career Highlights

David Karpf's career includes pivotal roles at prestigious companies such as Cymabay Therapeutics, Inc. and Ascendis Pharma Bone Diseases A/S. His work in these organizations has been instrumental in pushing the boundaries of drug development and enhancing treatment modalities for various bone diseases.

Collaborations

Throughout his career, Karpf has collaborated with esteemed colleagues, including Brian K. Roberts and Robert Louis Martin. These professional relationships have facilitated the exchange of ideas and innovations, further enriching the field of pharmaceutical research.

Conclusion

David Brian Karpf's contributions to innovation in pharmaceuticals demonstrate the vital role of inventors in advancing medical science. With his dedication to developing effective therapies, Karpf continues to impact the industry positively, paving the way for future breakthroughs in treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…